Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
In this phase 3 trial involving patients with persistant chylomicronemia, plozasiran, a short interfering RNA that targets APOC3, reduced triglyceride levels and the incidence...
NEJM at ESC — Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Invasive Treatment Strategy for Older Patients with Myocardial Infarction
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
NEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
